Schedule 13G ownership disclosure
OptimizeRx Corp
Common Stock · CUSIP: 68401U204
Event date: 2025-06-30
- Filing-level shares
- 790,640.00
- Percent of class
- 4.27%
- ROYCE & ASSOCIATES LP
Shares: 790,640.00 · Class: 4.27%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000906304-25-000129
- Form type
- SCHEDULE 13G/A
- Filer
- OptimizeRx Corp
- CIK
- CIK 1448431
- Filed
- Jul 16, 2025
- Reporting period
- Jun 30, 2025
- Description
- Schedule 13G beneficial ownership